(Press-News.org)
“NeXT Dx incorporates a range of features and comprehensive genome variant detection methods that lead to improved disease management and possible enhanced clinical utility.”
BUFFALO, NY- August 30, 2023 – A new research paper was published in Oncotarget's Volume 14 on August 30, 2023, entitled, “Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay.”
In this new research paper, researchers Juan-Sebastian Saldivar, Jason Harris, Erin Ayash, Manqing Hong, Prateek Tandon, Saloni Sinha, Patricia Miranda Hebron, Erin E. Houghton, Kaleigh Thorne, Laurie J. Goodman, Conan Li, Twinkal R. Marfatia, Joshua Anderson, Massimo Morra, John Lyle, Gabor Bartha, and Richard Chen from Personalis, Inc. describe the analytic validation of NeXT Dx, a comprehensive genomic profiling assay to aid therapy and clinical trial selection for patients diagnosed with solid tumor cancers.
“The NeXT Dx clinical report currently provides the ordering clinician with information from 401 cancer-related genes on clinically relevant mutations, as well as related drug response associations and a curated list of clinical trials that may be applicable to the patient.”
Proprietary methods were utilized to perform whole exome and whole transcriptome sequencing for detection of single nucleotide variants (SNVs), insertions/deletions (indels), copy number alterations (CNAs), and gene fusions, and determination of tumor mutation burden and microsatellite instability. Variant calling is enhanced by sequencing a patient-specific normal sample from, for example, a blood specimen. This provides highly accurate somatic variant calls as well as the incidental reporting of pathogenic and likely pathogenic germline alterations. Fusion detection via RNA sequencing provides more extensive and accurate fusion calling compared to DNA-based tests.
NeXT Dx features the proprietary Accuracy and Content Enhanced technology, developed to optimize sequencing and provide more uniform coverage across the exome. The exome was validated at a median sequencing depth of >500x. While variants from 401 cancer-associated genes are currently reported from the assay, the exome/transcriptome assay is broadly validated to enable reporting of additional variants as they become clinically relevant. NeXT Dx demonstrated analytic sensitivities as follows: SNVs (99.4%), indels (98.2%), CNAs (98.0%), and fusions (95.8%). The overall analytic specificity was >99.0%.
“By more comprehensively characterizing the molecular characteristics of each patient’s tumor, NeXT Dx provides personalized recommendations critical to clinical decision-making with respect to current FDA-approved drug-variant specific treatments and evolving treatment opportunities via enrollment in clinical trials.”
Read the full research paper: DOI: https://doi.org/10.18632/oncotarget.28490
Correspondence to: Richard Chen
Email: richard.chen@Personalis.com
Keywords: comprehensive genomic profiling, whole exome sequencing, whole transcriptome sequencing, tumor-normal, precision medicine
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
LabTube
Soundcloud
Sign up for free Altmetric alerts about this article: https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28490
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact: media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
Blake Meyers, a principal investigator at the Donald Danforth Plant Science Center and a professor of plant sciences from the University of Missouri - Columbia, has been named the new director and Novozymes Chair in Genomics at the UC Davis Genome Center. Meyers, who studies plant RNA biology, bioinformatics and functional genomics, will step into the role on March 1.
A member of the National Academy of Sciences, Meyers succeeds the center’s founding director Richard Michelmore, a distinguished professor in the departments of Plant Sciences, Molecular and Cellular Biology, and Medical Microbiology and Immunology.
Roots ...
NASA uses the International Space Station — a football field-sized spacecraft orbiting Earth — to learn more about living and working in space. For over 20 years, the space station has provided a unique platform for investigation and research in areas like biology, technology, agriculture, and more. It serves as a home for astronauts conducting experiments, including advancing NASA’s space communications capabilities.
In 2023, NASA is sending a technology demonstration known as the Integrated LCRD Low Earth Orbit User ...
A new study by researchers from Mass General Brigham further illustrates that when it comes to risk of Alzheimer’s disease, even genetically determined forms of the disease, genetics is only one piece of the puzzle. Researchers investigated the influence of genetics and educational attainment on cognitive decline by studying data from 675 people who carry a mutation that predisposes them to early onset Alzheimer’s disease. Carriers of this mutation—known as PSEN1 E280A—have a median age of 49 for onset of dementia. The team found that among ...
LAWRENCE, KANSAS — A new virtual institute established at the University of Kansas School of Engineering will train the next generation of military and civilian leaders to better combat the growing threat of cyberattacks and protect the electromagnetic spectrum (EMS).
KU received a two-year, $1.5 million grant from the Department of Defense to establish the program, known as the Virtual Institutes for Cyber and Electromagnetic Spectrum Research and Employ, or VICEROY, Virtual Institute. The grant is overseen by the Griffiss Institute, which is a nonprofit talent ...
Writing is an age-old cultural technique. Thousands of years ago, humans were already carving signs and symbols into stone slabs. Scripts have become far more sophisticated since then but one aspect remains the same: Whether the writer is using cuneiform or a modern alphabet, a solid substrate, such as clay or paper, is required to fix the written structures in place. However, researchers at Johannes Gutenberg University Mainz (JGU), TU Darmstadt, and Wuhan University asked themselves how to write in a bulk fluid like water without fixing substrates. The concept would not be unlike the way aircraft leave three-dimensional vapor trails behind them when they ...
About one in every five people carries a version of a gene that, although largely unsung, appears to confer protection against both Alzheimer’s disease and Parkinson’s disease, Stanford Medicine investigators and their colleagues have learned. These lucky people may someday benefit all the more from a vaccine that could slow or stall the progression of these two most common neurodegenerative conditions.
An analysis of medical and genetic data from hundreds of thousands of people of diverse ancestries from several continents has revealed ...
First-time fathers seem to experience a steeper decline in relationship satisfaction in the first two years post-partum than second-time fathers, who appear to recover lost relationship satisfaction by the time their second child is 14 months old, according to a study published August 30, 2023 in the open-access journal PLOS ONE by Judith T. Mack and Lena Brunke from Technische Universität Dresden, Germany, and colleagues.
Having a strong primary relationship can help couples more successfully weather potentially-challenging transitions like the birth of a child. Most research on ...
Detailed analysis of two Late Bronze Age urn burials uncovers animal bones and jewelry amidst the cremated remains of a woman and child, and reveals insights into prehistoric funerary rites
###
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0289140
Article Title: More than urns: A multi-method pipeline for analyzing cremation burials
Author Countries: Austria, Slovakia, Czech Republic, Belgium
Funding: This study was funded by the Austrian Science Fund (FWF) in the framework of the project ‘Unlocking the secrets ...
DURHAM, N.C. – A man-made antibody successfully prevented organ rejection when tested in primates that had undergone a kidney transplant, Duke Health researchers report.
The finding clears the way for the new monoclonal antibody to move forward in human clinical trials. Results of the study appear online Aug. 30 in the journal Science Translational Medicine.
“Current medications to prevent organ rejection are good overall, but they have a lot of side effects,” said lead author Imran J. Anwar, M.D., a surgical research fellow ...
DURHAM, N.C. – Researchers have developed a blood test that detects Parkinson’s disease, potentially establishing a way to help diagnose the condition before nervous system damage worsens.
A new blood-based diagnostic test would be a major advancement for Parkinson’s disease, which afflicts 10 million people worldwide and is the second-most common neurodegenerative disease after Alzheimer’s. Led by a team of Duke Health neuroscientists, the study appears Aug. 30 in the journal Science Translational Medicine.
“Currently, Parkinson’s disease is diagnosed largely based on clinical symptoms after significant neurological damage has ...
